Novatemed Innoceuticals Inc. – Trademark Portfolio
Entity Type: 03
Novatemed Innoceuticals Inc. holds 2 U.S. trademarks filed with the United States Patent and Trademark Office (USPTO), with a strong focus on Class 3 (Cosmetics & Cleaning) — 2 filings in this category. The portfolio also extends into Class 5 (Pharmaceuticals) across 2 Nice Classification classes. Currently, 1 trademark is registered. Notable registered marks include DR. MERAL'S ELIXIR. The owner is based in Fort Lauderdale, FL.
The Concept Law Group. P.A.
6400 N. Andrews Ave., Ste. 500
Fort Lauderdale, FL 33309
Showing of trademarks Trademarks
Trademark Classifications
Novatemed Innoceuticals Inc.'s trademark portfolio spans 2 Nice Classification classes, reflecting the scope of goods and services protected under their brand portfolio.
Bleaching preparations and other substances for laundry use; cleaning, polishing, scouring
Pharmaceutical and veterinary preparations; sanitary preparations for medical purposes
Frequently Asked Questions
How many trademarks does Novatemed Innoceuticals Inc. have?
Novatemed Innoceuticals Inc. has 2 U.S. trademarks filed with the USPTO. Of these, 1 registered, 1 abandoned.
What trademark classes does Novatemed Innoceuticals Inc. file in?
Novatemed Innoceuticals Inc. files trademarks across 2 Nice Classification classes. The most active classes are Class 3 (Cosmetics & Cleaning), Class 5 (Pharmaceuticals). Class 3 covers bleaching preparations and other substances for laundry use; cleaning, polishing, scouring.
What are Novatemed Innoceuticals Inc.'s most well-known trademarks?
Novatemed Innoceuticals Inc.'s registered trademark portfolio includes well-known marks such as DR. MERAL'S ELIXIR. These are among 1 currently registered trademark in the portfolio.
What is Novatemed Innoceuticals Inc.'s trademark registration success rate?
Novatemed Innoceuticals Inc. has a 50% trademark registration rate, with 1 out of 2 resolved applications resulting in successful registration. Currently, 0 applications are pending review.